FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “DABNOLIA”, which is offered here for Recombinant monoclonal antibodies directed against the rhesus d antigen.
Its status is currently believed to be active. Its class is “Pharmaceuticals”. “DABNOLIA” is believed to be currently owned by “LABORATOIRE FRANCAIS DU; FRACTIONNEMENT; ET DES BIOTECHNOLOGIES”.
Owner: |
LABORATOIRE FRANCAIS DU; FRACTIONNEMENT; ET DES BIOTECHNOLOGIES
Owner Details
|
---|---|
Description: |
Recombinant monoclonal antibodies directed against the Rhesus D antigen
|
Categories: | RECOMBINANT MONOCLONAL ANTIBODIES |